CEN Biotech Inc. Announces Pending Launch of WordPresto


CEN Biotech Inc. (OTCQB: CENBF)

WINDSOR, ONTARIO, CANADA, Sept. 16, 2022 /EINPresswire.com/ — CEN Biotech Inc. (“CEN” or the “Company”) (OTCQB: CENBF), a global holding company focused on developing advanced digital technologies multimedia technologies, LED lighting technology and hemp products is pleased to announce the planned launch of its newest technology product, WordPresto (www.wordpresto.com) on September 28, 2022 at 11:00 a.m. EDT. This launch event will be streamed on Facebook Live and YouTube Live and will showcase WordPresto’s capabilities to revolutionize the web design market and meet the needs of scalable and affordable web design.

Date: September 28, 2022
Time: 11:00 a.m. EDT / 8:00 a.m. PDT
Location: www.wordpresto.com (links to live events on Facebook and YouTube from homepage)

WordPresto is both a product and a service that aims to provide users with a personalized web design experience that uses WordPress as its primary content management system as its web platform. WordPresto aims to provide interactive and personalized web design technologies and services coupled with affordable ongoing support and maintenance. Our team aims to work from scratch to quickly and cost-effectively create an eloquent website that gives users a personalized look and feel. With WordPresto, all you have to do is communicate your needs, provide ongoing feedback, and let our experts do the rest. It starts with selecting a website package that best meets your business needs based on industry, overall goals and objectives, and other marketing efforts in place. Each website package includes image and software licenses, professional design and development, security updates and patches, business hosting, project management, and support and ongoing maintenance.

The launch event will be hosted by Larry Lehoux, the company’s president and chief technology officer, who said, “WordPresto is the first scheduled launch of a new line of products being developed by CEN. We are very pleased to offer and continue to seek to develop leading consumer and business-focused products that use artificial intelligence-based technologies designed to make website development and maintenance more efficient and affordable. . CEN has fully embraced the power of artificial intelligence and intends to design a series of products and services that use AI technologies to make everyday life easier, more efficient, informative and entertaining.

About CEN Biotech Inc.
CEN Biotech, Inc. is a global holding company focused on the development of digital media and LED lighting technologies and hemp-based products. For more information about the company, please visit our website at www.cenbiotechinc.com. Information about the Company can also be found on the Securities and Exchange Commission’s EDGAR site under the issuer profile of “CEN Biotech Inc.”

Caution Regarding Forward-Looking Statements
This press release contains “forward-looking” statements. In particular, the words “believe”, “may”, “could”, “should”, “expect”, “anticipate”, “estimate”, “project”, “propose”, “plan”, “have intent” and similar conditional words and phrases are intended to identify forward-looking statements. All statements made in this press release about any action, event or development are forward-looking. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions, many of which may be beyond CEN’s control, that could cause actual results to differ materially from those in the forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. Although CEN believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be accurate. Potential risks include factors such as the inability to enter into agreements with parties with whom we are in discussions, factors that cannot be predicted with certainty, and additional risks and uncertainties that are identified and described in the CEN reports filed with the Securities and Exchange Commission (the “SEC”). Investors are cautioned that forward-looking statements are not guarantees of future performance and that actual results or developments may differ materially from those projected. Actual results may differ materially from the forward-looking statements contained in this press release. Statements made herein are as of the date of this press release and should not be relied upon at any later date. CEN does not undertake and specifically disclaims any obligation to update any forward-looking statements to reflect events, developments, events or circumstances after the date of this statement, except as required by applicable law.

press contact
Brian S. Payne
Chief executive officer
CEN Biotech Inc.
Telephone: (519) 981-0970
Email: [email protected]
Email: [email protected]

Brian Payne
CEN Biotech Inc.
write to us here


Comments are closed.